Back to news

BrightSpring Health Services Gains as Strong Q3 Results and Higher Guidance Support Shares

Investivoq PriceTracker

BrightSpring Health Services (BTSG) is up 4.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued investor reaction to BrightSpring’s recent third-quarter results, which showed strong growth and a higher full-year outlook. Additional support may have come from follow-on bullish analyst target increases after the earnings release, reinforcing confidence in the company’s pharmacy and provider services momentum.

Details:

  • BrightSpring announced third-quarter 2026 results on October 30, with net revenue rising to about $4.2 billion, up more than 26% from a year earlier.
  • Net income from continuing operations increased sharply year over year, while gross profit also climbed, pointing to stronger operating performance.
  • The company raised its full-year 2026 revenue and adjusted EBITDA guidance, giving investors a clearer signal that management sees sustained demand and execution.
  • In the days after the report, several Wall Street firms lifted their price targets, which likely helped extend the positive move in the stock.

    • Sources:

    BrightSpring Health Services, SEC, Yahoo Finance, S&P Global

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $BTSG Insider Trading Activity

    BTSG Insider Trades

    $BTSG insiders have traded $BTSG stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

    Here’s a breakdown of recent trading of $BTSG stock by insiders over the last 6 months:

    • GROUP PARTNERSHIP L.P. KKR sold 14,669,771 shares for an estimated $857,492,124
    • PHOENIX AGGREGATOR L.P. KKR sold 14,669,771 shares for an estimated $857,492,124
    • JON B ROUSSEAU (See Remarks) has made 0 purchases and 2 sales selling 260,000 shares for an estimated $15,275,000.
    • LISA A NALLEY (See Remarks) sold 35,000 shares for an estimated $2,056,250
    • JENNIFER A PHIPPS (Chief Financial Officer) sold 35,000 shares for an estimated $2,056,250
    • SCOTT A. GREENWELL (President, PharMerica) sold 15,099 shares for an estimated $874,383

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive BTSG Data Alerts
    Get market-moving data, filings, and signals for BTSG in real time.
    Sign Up

    $BTSG Hedge Fund Activity

    We have seen 300 institutional investors add shares of $BTSG stock to their portfolio, and 170 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 14,994,379 shares (-35.9%) from their portfolio in Q2 2026, for an estimated $1,045,707,991
    • T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 4,968,554 shares (+462.9%) to their portfolio in Q2 2026, for an estimated $346,506,955
    • BLACKROCK, INC. added 4,425,378 shares (+22.6%) to their portfolio in Q2 2026, for an estimated $308,625,861
    • FMR LLC added 3,972,454 shares (+29.7%) to their portfolio in Q3 2026, for an estimated $225,436,764
    • AMERICAN CENTURY COMPANIES INC added 3,291,039 shares (+inf%) to their portfolio in Q2 2026, for an estimated $229,517,059
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,889,829 shares (+inf%) to their portfolio in Q2 2026, for an estimated $131,796,674
    • NORGES BANK added 1,889,492 shares (+2845.1%) to their portfolio in Q2 2026, for an estimated $131,773,172

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $BTSG Price Targets

    Multiple analysts have issued price targets for $BTSG recently. We have seen 6 analysts offer price targets for $BTSG in the last 6 months, with a median target of $79.0.

    Here are some recent targets:

    • A.J. Rice from UBS set a target price of $85.0 on 07/08/2026
    • Kevin Fischbeck from B of A Securities set a target price of $77.0 on 07/02/2026
    • David Larsen from BTIG set a target price of $90.0 on 06/22/2026
    • Charles Rhyee from TD Cowen set a target price of $81.0 on 06/18/2026
    • Scott Fidel from Goldman Sachs set a target price of $71.0 on 06/08/2026
    • Erin Wright from Morgan Stanley set a target price of $71.0 on 06/02/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.